Vaccination schedule
HPV vaccine coverage very low among Greek boys
Only a very small percentage of boys in Greece have received the human papillomavirus (HPV) vaccine.
Despite the fact that this vaccine is one of the two for cancer prevention, less than one in 10 boys aged 9 and older have had it. And this is despite the fact that since April 2022 it has been included in the National Vaccination Program and is therefore administered free of charge.
- Read more about HPV vaccine coverage very low among Greek boys
- Log in to post comments
Budget passed as PM refers to ‘Freedom’ campaign
People walk in Syntagma Square in front of the Greek Parliament, which, on Tuesday, after a five day debate, approved the 2021 budget, whose text foresees a 10.5% contraction in 2020 due to the effects of the pandemic.
- Read more about Budget passed as PM refers to ‘Freedom’ campaign
- Log in to post comments
Phase 1 trials of local vaccine completed
Phase 1 trials of a potential vaccine developed by Erciyes University in the Central Anatolian province of Kayseri have been completed without any serious side effects on the volunteers, the dean of the university has said
The first doses of the ERUCOV-VAC vaccine were administered to 44 volunteers in early November and the second doses started to be injected on Nov. 26.
- Read more about Phase 1 trials of local vaccine completed
- Log in to post comments
Phase 2 trial for local vaccine set for December 25
The phase two trials of the Turkish-made COVID-19 vaccine will begin on Dec. 25, Health Minister Fahrettin Koca has announced.
Covid-19: First Person Receives Pfizer Covid-19 Vaccine in UK
A 90-year-old woman has become the first person to be given a Covid jab as part of the mass vaccination programme being rolled out across the UK.
Margaret Keenan, who turns 91 next week, said it was the "best early birthday present".
The Big Decision of the World - Who Will Get the Covid-19 Vaccine First?
In theory, everyone in the world who wants it should eventually be able to get immunized. But for much of 2021, demand for the coronavirus vaccine will outstrip supply, presenting a massive dilemma for governments, which must decide who gets the vaccine first or early, and who must wait.